Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 761852, 9 pages
http://dx.doi.org/10.1155/2013/761852
Research Article

[6]-Gingerol Prevents Disassembly of Cell Junctions and Activities of MMPs in Invasive Human Pancreas Cancer Cells through ERK/NF-κB/Snail Signal Transduction Pathway

Department of Herbal Pharmacology, College of Oriental Medicine, Daegu Haany University, 165 Sang Dong, Suseong gu, Daegu 706-828, Republic of Korea

Received 24 May 2013; Revised 15 July 2013; Accepted 14 August 2013

Academic Editor: Dan-Ning Hu

Copyright © 2013 Sung Ok Kim and Mi Ryeo Kim. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Sung, S. Prasad, V. R. Yadav, and B. B. Aggarwal, “Cancer cell signaling pathways targeted by spice-derived nutraceuticals,” Nutrition and Cancer, vol. 64, no. 2, pp. 173–197, 2013. View at Google Scholar
  2. P. Michl, C. Barth, M. Buchholz et al., “Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer,” Cancer Research, vol. 63, no. 19, pp. 6265–6271, 2003. View at Google Scholar · View at Scopus
  3. Z. E. Karanjawala, P. B. Illei, R. Ashfaq et al., “New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8,” American Journal of Surgical Pathology, vol. 32, no. 2, pp. 188–196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Anderson and C. M. Van Itallie, “Tight junctions and the molecular basis for regulation of paracellular permeability,” American Journal of Physiology, vol. 269, no. 4, pp. G467–G475, 1995. View at Google Scholar · View at Scopus
  5. P. J. Morin, “Claudin proteins in human cancer: promising new targets for diagnosis and therapy,” Cancer Research, vol. 65, no. 21, pp. 9603–9606, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. W. Jung, Y. J. Won, H. J. Kong et al., “Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010,” Cancer Research and Treatment, vol. 45, no. 1, pp. 1–14, 2013. View at Google Scholar
  8. S. S. Devesa, W. J. Blot, B. J. Stone, B. A. Miller, R. E. Tarone, and J. F. Fraumeni Jr., “Recent cancer trends in the United States,” Journal of the National Cancer Institute, vol. 87, no. 3, pp. 175–182, 1995. View at Google Scholar · View at Scopus
  9. World Cancer Research Fund & American Institute for Cancer Research, “1997 World Cancer Research Fund & American Institute for Cancer Research,” Food, Nutrition and the Prevention of Cancer: A Global Perspective American Institute for Cancer Research, Washington, DC, USA, 1997.
  10. B. White, “Ginger: an overview,” American Family Physician, vol. 75, no. 11, pp. 1689–1691, 2007. View at Google Scholar · View at Scopus
  11. Y. Shukla and M. Singh, “Cancer preventive properties of ginger: a brief review,” Food and Chemical Toxicology, vol. 45, no. 5, pp. 683–690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. R. C. Lantz, G. J. Chen, M. Sarihan, A. M. Sólyom, S. D. Jolad, and B. N. Timmermann, “The effect of extracts from ginger rhizome on inflammatory mediator production,” Phytomedicine, vol. 14, no. 2-3, pp. 123–128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-J. Surh, “Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances,” Mutation Research, vol. 428, no. 1-2, pp. 305–327, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. B. H. Ali, G. Blunden, M. O. Tanira, and A. Nemmar, “Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research,” Food and Chemical Toxicology, vol. 46, no. 2, pp. 409–420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. P. Soler, R. D. Miller, K. V. Laughlin, N. Z. Carp, D. M. Klurfeld, and J. M. Mullin, “Increased tight junctional permeability is associated with the development of colon cancer,” Carcinogenesis, vol. 20, no. 8, pp. 1425–1431, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. B. M. Gumbiner, “Breaking through the tight junction barrier,” Journal of Cell Biology, vol. 123, no. 6, pp. 1631–1633, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. E. E. Schneeberger and R. D. Lynch, “The tight junction: a multifunctional complex,” American Journal of Physiology, vol. 286, no. 6, pp. C1213–C1228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. K. B. Hoover, S.-Y. Liao, and P. J. Bryant, “Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity,” American Journal of Pathology, vol. 153, no. 6, pp. 1767–1773, 1998. View at Google Scholar · View at Scopus
  19. S. S. De Oliveira, I. M. De Oliveira, W. De Souza, and J. A. Morgado-Díaz, “Claudins upregulation in human colorectal cancer,” FEBS Letters, vol. 579, no. 27, pp. 6179–6185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. C. Cunningham, F. Kamangar, M. P. Kim et al., “Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 2, pp. 281–287, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. L. B. A. Rangel, R. Agarwal, T. D'Souza et al., “Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas,” Clinical Cancer Research, vol. 9, no. 7, pp. 2567–2575, 2003. View at Google Scholar · View at Scopus
  22. S. L. Kominsky, M. Vali, D. Korz et al., “Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4,” American Journal of Pathology, vol. 164, no. 5, pp. 1627–1633, 2004. View at Google Scholar · View at Scopus
  23. H. Long, C. D. Crean, W.-H. Lee, O. W. Cummings, and T. G. Gabig, “Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium,” Cancer Research, vol. 61, no. 21, pp. 7878–7881, 2001. View at Google Scholar · View at Scopus
  24. R. W. McLachlan and A. S. Yap, “Not so simple: the complexity of phosphotyrosine signaling at cadherin adhesive contacts,” Journal of Molecular Medicine, vol. 85, no. 6, pp. 545–554, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C. M. Van Itallie and J. M. Anderson, “Claudins and epithelial paracellular transport,” Annual Review of Physiology, vol. 68, pp. 403–429, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Cowin, T. M. Rowlands, and S. J. Hatsell, “Cadherins and catenins in breast cancer,” Current Opinion in Cell Biology, vol. 17, no. 5, pp. 499–508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. J. Blanco, G. Moreno-Bueno, D. Sarrio et al., “Correlation of Snail expression with histological grade and lymph node status in breast carcinomas,” Oncogene, vol. 21, no. 20, pp. 3241–3246, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-W. Cheng, P.-E. Wu, J.-C. Yu et al., “Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene,” Oncogene, vol. 20, no. 29, pp. 3814–3823, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. S. E. Moody, D. Perez, T.-C. Pan et al., “The transcriptional repressor Snail promotes mammary tumor recurrence,” Cancer Cell, vol. 8, no. 3, pp. 197–209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Voorzanger-Rousselot and P. Garnero, “Biochemical markers in oncology—part 1: molecular basis—part 2: clinical uses,” Cancer Treatment Reviews, vol. 33, no. 3, pp. 230–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. S. D. Mason and J. A. Joyce, “Proteolytic networks in cancer,” Trends in Cell Biology, vol. 21, no. 4, pp. 228–237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Durlik and K. Gardian, “Metalloproteinase 2 and 9 activity in the development of pancreatic cancer,” Polish Journal of Surgery, vol. 84, no. 8, pp. 377–382, 2012. View at Google Scholar
  33. P. Dhawan, A. B. Singh, N. G. Deane et al., “Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer,” Journal of Clinical Investigation, vol. 115, no. 7, pp. 1765–1776, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Shishodia and B. B. Aggarwal, “Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer,” Cancer Treatment and Research, vol. 119, pp. 139–173, 2004. View at Google Scholar · View at Scopus
  35. S. Prasad, V. R. Yadav, C. Sundaram et al., “Crotepoxide chemosensitizes tumor cells through inhibition of expression of proliferation, invasion, and angiogenic proteins linked to proinflammatory pathway,” Journal of Biological Chemistry, vol. 285, no. 35, pp. 26987–26997, 2010. View at Publisher · View at Google Scholar · View at Scopus